Drug intelligence / Profile preview

sulfadimidine

Development stage
Unknown
Lead developer
Pannonpharma
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Septosyl is a topical ophthalmic antibiotic ointment containing sulfadimidine (also known as sulfamethazine). Developed and marketed by the Hungarian company PannonPharma, it belongs to the sulfonamide class of antibiotics. The drug exerts its bacteriostatic effect by competitively inhibiting the enzyme dihydropteroate synthase (DHPS), which is a critical step in the bacterial synthesis of folic acid. By blocking the production of dihydrofolic acid, it prevents bacterial nucleic acid synthesis and growth. Septosyl is primarily indicated for the treatment of superficial bacterial infections of the eye, including conjunctivitis, blepharitis, and keratitis, and is also used for the prevention of neonatal ophthalmia caused by susceptible organisms.

Brand names
Septosyl
Other names
sulfamethazinesulfadimerazinesulfadimidinumsulphadimidine
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on sulfadimidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sulfadimidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call